---
title: "SCN1A gain-of-function mouse model shows inhibitory neuron dysfunction causes epilepsy and early d"
id: "biorxiv-12-epilepsy-and-premature-mortality-driven-by-inhibitory-neuron-dysfunction-in-a"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-12-epilepsy-and-premature-mortality-driven-by-inhibitory-neuron-dysfunction-in-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1?rss=1"
published_at: "2026-08-09T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# SCN1A gain-of-function mouse model shows inhibitory neuron dysfunction causes epilepsy and early d
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-12-epilepsy-and-premature-mortality-driven-by-inhibitory-neuron-dysfunction-in-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1?rss=1)
- **Published At:** 2026-08-09T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study models a recurrent patient variant in **SCN1A**, which encodes the neuronal sodium channel **NaV1.1**, producing **gain-of-function** (GoF) effects distinct from classic loss-of-function Dravet syndrome presentations. - Authors generated a heterozygous, Cre-dependent mouse allele expressing the patient variant **Scn1a-p.R1636Q** to study pathophysiology in vivo. - Global expression of the mutant allele caused spontaneous convulsive seizures and resulted in **100% premature mortality** of mutant mice between postnatal day 12–18. - Cell-type–specific activation showed that expression of the mutant allele in **parvalbumin interneurons** (using Dlx5/6-Cre or PV-Cre) reproduced the epilepsy and premature mortality phenotypes. - Activation of the mutant allele in excitatory neurons (Slc17a7-Cre) or other interneuron subtypes (VIP-Cre, Sst-Cre) did not reproduce the lethal epilepsy phenotype, implicating dysfunction of PV interneurons as the primary driver. - Treatment with the sodium channel blocker **GS967** significantly prolonged lifespan in mutant mice, indicating therapeutic potential of sodium channel blockade in this GoF model. - This is the first in vivo preclinical model of **SCN1A** GoF epilepsy, providing a platform for mechanistic studies and therapeutic development. - The report is a preprint and has not undergone peer review; additional experimental details and broader validation remain to be reported in peer-reviewed publication.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=o8fNGDuIOKKZs2mX9IO1kAobGkAz0FFUStdiledw6To-1786334471.4191484-1.2.1.1-vi_FUEn0Ne_pYYXOR8qUTgKA1J1o3TolOaZtVWper6c) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Epilepsy and premature mortality driven by inhibitory neuron dysfunction in a mouse model of _SCN1A_ gain-of-function neurodevelopmental disorder [ View ORCID Profile](http://orcid.org/0000-0002-8331-9812)Sophie F Hill, Zachary P. Rosenthal, [ View ORCID Profile](http://orcid.org/0000-0002-7404-735X)Ethan M Goldberg doi: https://doi.org/10.64898/2026.08.04.742893 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Sophie F Hill 1 The Children's Hospital of Philadelphia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sophie%2BF%2BHill%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hill%20SF&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASophie%2BF%2BHill%2B) * [ORCID record for Sophie F Hill](http://orcid.org/0000-0002-8331-9812 "Open in new tab") Zachary P. Rosenthal 2 The Perelman School of Medicine at the University of Pennsylvania * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zachary%2BP.%2BRosenthal%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Rosenthal%20ZP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AZachary%2BP.%2BRosenthal%2B) Ethan M Goldberg 1 The Children's Hospital of Philadelphia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ethan%2BM%2BGoldberg%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Goldberg%20EM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AEthan%2BM%2BGoldberg%2B) * [ORCID record for Ethan M Goldberg](http://orcid.org/0000-0002-7404-735X "Open in new tab") * For correspondence: goldberge@email.chop.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5691735/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5691735/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5691735/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5691735/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The gene most commonly implicated in epilepsy, _SCN1A_ , encodes the neuronal voltage-gated sodium channel α subunit NaV1.1. _SCN1A_ variants that reduce sodium current (″loss of function″ variants) cause Dravet syndrome, a neurodevelopmental disorder defined by treatment-resistant temperature sensitive epilepsy with onset at/around 5 months of age, developmental delay/intellectual disability, and features of or formal diagnosis autism. However, an emerging group of variants cause ″gain of function″ (GoF) effects on NaV1.1 and result in a distinct presentation with earlier onset than Dravet syndrome and prominent movement disorder but without temperature sensitivity. We developed the first mouse model of _SCN1A_ GoF epilepsy with heterozygous Cre-dependent expression of the recurrent patient variant _Scn1a_ -p.R1636Q. Global expression of this variant causes premature mortality in 100% (64/64) of mutant mice between postnatal day 12-18 due to spontaneous, convulsive seizures. Activation of the mutant allele in parvalbumin interneurons (_Dlx5/6-Cre_ or _PV-Cre_), but not excitatory neurons (_Slc17a7-Cre_) or other interneuron subtypes (_VIP-Cre_ or _Sst-Cre_), recapitulates the premature mortality and epilepsy phenotypes. Treatment of _Scn1a_ -p.R1636Q mutant mice with the sodium channel blocker GS967 markedly prolongs lifespan. This work is the first study of _SCN1A_ GoF epilepsy in a preclinical model in vivo. Further investigation in the _Scn1a_ flox(R1636Q) mouse will yield new mechanistic insights into disease mechanisms to drive advances in the treatment of _SCN1A_ GoF epilepsy. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared National Institute of Neurological Disorders and Stroke, NS110869 Dravet Syndrome Foundation, https://ror.org/018hh3649, Research Grant, Postdoctoral Fellowship Philadelphia Foundation, Brody Family Medical Trust Fellowship in Incurable Diseases Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.08.04.742789v1 "Scop3P-Toolkit: executable structure-aware workflows linking PTMs, peptides, and mutations to protein function") Posted August 09, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.08.04.742893v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/08/09/2026.08.04.742893.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Epilepsy and premature mortality driven by inhibitory neuron dysfunction in a mouse model of _SCN1A_ gain-of-function neurodevelopmental disorder Sophie F Hill, Zachary P. Rosenthal, Ethan M Goldberg bioRxiv 2026.08.04.742893; doi: https://doi.org/10.64898/2026.08.04.742893 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.08.04.742893v1%26text%3DEpilepsy%2520and%2520premature%2520mortality%2520driven%2520by%2520inhibitory%2520neuron%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520SCN1A%2520gain-of-function%2520neurodevelopmental%2520disorder "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.08.04.742893v1%26t%3DEpilepsy%2520and%2520premature%2520mortality%2520driven%2520by%2520inhibitory%2520neuron%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520SCN1A%2520gain-of-function%2520neurodevelopmental%2520disorder "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.08.04.742893v1%26title%3DEpilepsy%2520and%2520premature%2520mortality%2520driven%2520by%2520inhibitory%2520neuron%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520SCN1A%2520gain-of-function%2520neurodevelopmental%2520disorder%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.08.04.742893v1%26title%3DEpilepsy%2520and%2520premature%2520mortality%2520driven%2520by%2520inhibitory%2520neuron%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520SCN1A%2520gain-of-function%2520neurodevelopmental%2520disorder "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.08.04.742893) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.08.04.742893v1&count=horizontal&via=&text=Epilepsy%20and%20premature%20mortality%20driven%20by%20inhibitory%20neuron%20dysfunction%20in%20a%20mouse%20model%20of%20SCN1A%20gain-of-function%20neurodevelopmental%20disorder&counturl=www.biorxiv.org/content/10.64898/2026.08.04.742893v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (7873) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (18406) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (14577) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (43534) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22182) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (19294) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (26424) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (13759) * [Ecology](https://www.biorxiv.org/collection/ecology) (20614) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (25059) * [Genetics](https://www.biorxiv.org/collection/genetics) (15964) * [Genomics](https://www.biorxiv.org/collection/genomics) (23187) * [Immunology](https://www.biorxiv.org/collection/immunology) (18371) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (41754) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (17725) * [Neuroscience](https://www.biorxiv.org/collection/neuroscience) (91765) * [Paleontology](https://www.biorxiv.org/collection/paleontology) (686) * [Pathology](https://www.biorxiv.or
## Related Clinical Research

- [EEG-derived indices classify sporadic Creutzfeldt-Jakob disease from Alzheimer’s and healthy aging](https://medichelpline.com/clinical-feed/plos-one-17-classification-of-sporadic-creutzfeldt-jakob-disease-based-on-resting-state.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries](https://medichelpline.com/clinical-feed/clinicaltrials-nct05819008.md) (DOI: NCT05819008)
- [Two scientists to receive 2026 Ralph L. Sacco Scholarships for Brain Health](https://medichelpline.com/clinical-feed/aha-news-8-two-scientists-to-receive-2026-ralph-l-sacco-scholarships-for-brain-health.md)
- [CAMSAP3 loss-of-function evidence implicates gene in generalized genetic epilepsy](https://medichelpline.com/clinical-feed/biorxiv-1-camsap3-loss-of-function-models-suggest-causative-role-in-generalized-genetic.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.